Brain, Vol. 116, No. 6, 1399-1423, 1993
© 1993 Guarantors of Brain
research-article |
The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis
A neuropsychological and positron emission tomography study
1University Department of Neurology, Institute of Psychiatry and King's College School of Medicine and Dentistry Queen Square, London 2MRC Cyclotron Unit, Hammersmith Hospital Queen Square, London 3Department of Psychology, Institute of Psychiatry Queen Square, London 4Institute of Neurology Queen Square, London 5Department of Experimental Psychology Oxford, UK
Correspondence to:
Correspondence to: Dr J. J. M. Kew, MRC Cyclotron Unit, Hammersmith Hospital, Du Cane Road, London W12 OHS, UK.
Neuropsycholoical assessment of 16 clinically non-demented patients with amyotrophic lateral sclerosis (ALS) and 16 age-matched controls revealed significantly (P < 0.05) impaired verbal fluency and picture recall in the ALS patients. On the basis of their verbal fluency scores, two subgroups of the ALS patients (five high, five low scores) and a different group of give age-matched controls then underwent positron emission tomographic (PET) measurement of regional cerebral blood flow (rCBF). Scans were performed in the resting state and while subjects performed stereotyped or freely selected movements of a joystick with their right hand. The pattern of cerebral activation associated with self-generated activity was determined by comparing the profile of rCBF during freely selected and stereotyped joystick movements. Statistical parametric mapping was used to determine significant differences in rCBF between the groups at rest and during activation.
Regional cerebral blood flow at rest was significantly (P < 0.01) reduced in the anterior cingulate cortex of both ALS subgroups in comparison with controls. The profile of cortical and subcortical activation during performance of freely selected joystick movements relative to stereotyped movements was abnormal in ALS patients: (i) ALS patients with a normal fluency score showed significantly (P < 0.01) attenuated rCBF responses in comparison with controls in the left medial prefrontal cortex (Brodmann area 10) and the right and left parahippocampal gyri;(ii) ALS patients with impaired verbal fluency showed significantly (P < 0.01) attenuated rCBF responses in comparison with controls in the right and left medial prefrontal cortex (areas 9 and 10), the rostral aspects of the right anterior cingulate cortex (areas 24 and 32), the right parahippocampal gyrus and the anterior thalamic nuclear complex; (iii) ALS patients with impaired verbal fluency showed significantly (P < 0.01) attenuated rCBF responses in comparison with patients with normal verbal fluency in the right parahippocampal gyrus, the anterior thalamic nuclear complex and the rostral anterior cingulate cortex (area 24). Regional cerebral blood flow at rest in the right parahippocampal gyrus of ALS patients was significantly correlated with verbal fluency score (P = 0.01) and picture recall score (P = 0.01). Activation of the anterior thalamic nuclear complex in ALS patients was also significantly correlated with verbal fluency score (P = 0.001) and picture recall score (P = 0.01).
The results show that abnormalities of function are present in regions along a limbothalamo-cortical pathway in some ALS patients during performance of a self-generated motor task. Those ALS patients with impaired verbal fluency show more significantly impaired function in these regions than ALS patients with normal verbal fluency. The findings support the view that dysfunction of cortical neurons in ALS extends beyond those contributing to the corticospinal tract.
Received May 13, 1993. Revised July 22, 1993. Accepted August 18, 1993.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J Lakerveld, B Kotchoubey, and A Kubler Cognitive function in patients with late stage amyotrophic lateral sclerosis J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 25 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Irwin, C. F. Lippa, and J.M. Swearer Cognition and Amyotrophic Lateral Sclerosis (ALS) American Journal of Alzheimer's Disease and Other Dementias, September 1, 2007; 22(4): 300 - 312. [Abstract] [PDF] |
||||
![]() |
M. Morita, A. Al-Chalabi, P. M. Andersen, B. Hosler, P. Sapp, E. Englund, J. E. Mitchell, J. J. Habgood, J. de Belleroche, J. Xi, et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia Neurology, March 28, 2006; 66(6): 839 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Rippon, N. Scarmeas, P. H. Gordon, P. L. Murphy, S. M. Albert, H. Mitsumoto, K. Marder, L. P. Rowland, and Y. Stern An Observational Study of Cognitive Impairment in Amyotrophic Lateral Sclerosis. Arch Neurol, March 1, 2006; 63(3): 345 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Ringholz, S. H. Appel, M. Bradshaw, N. A. Cooke, D. M. Mosnik, and P. E. Schulz Prevalence and patterns of cognitive impairment in sporadic ALS Neurology, August 23, 2005; 65(4): 586 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Turner, A. Hammers, A. Al-Chalabi, C. E. Shaw, P. M. Andersen, D. J. Brooks, and P. N. Leigh Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET Brain, June 1, 2005; 128(6): 1323 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Abrahams, P. N. Leigh, and L. H. Goldstein Cognitive change in ALS: A prospective study Neurology, April 12, 2005; 64(7): 1222 - 1226. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Abrahams, L. H. Goldstein, A. Simmons, M. Brammer, S. C. R. Williams, V. Giampietro, and P. N. Leigh Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study Brain, July 1, 2004; 127(7): 1507 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maekawa, S. Al-Sarraj, M. Kibble, S. Landau, J. Parnavelas, D. Cotter, I. Everall, and P. N. Leigh Cortical selective vulnerability in motor neuron disease: a morphometric study Brain, June 1, 2004; 127(6): 1237 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sach, G. Winkler, V. Glauche, J. Liepert, B. Heimbach, M. A. Koch, C. Buchel, and C. Weiller Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis Brain, February 1, 2004; 127(2): 340 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ellis, J. Suckling, E. Amaro Jr., E. T. Bullmore, A. Simmons, S. C.R. Williams, and P. N. Leigh Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS Neurology, November 13, 2001; 57(9): 1571 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
I C Newsom-Davis, R A Lyall, P N Leigh, J Moxham, and L H Goldstein The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study J. Neurol. Neurosurg. Psychiatry, October 1, 2001; 71(4): 482 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Le Forestier, T. Maisonobe, A. Piquard, S. Rivaud, L. Crevier-Buchman, F. Salachas, P.-F. Pradat, L. Lacomblez, and V. Meininger Does primary lateral sclerosis exist?: A study of 20 patients and a review of the literature Brain, October 1, 2001; 124(10): 1989 - 1999. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Lloyd, M. P. Richardson, D. J. Brooks, A. Al-Chalabi, and P. N. Leigh Extramotor involvement in ALS: PET studies with the GABAA ligand [11C]flumazenil Brain, November 1, 2000; 123(11): 2289 - 2296. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Strong, G. M. Grace, J. B. Orange, H. A. Leeper, R. S. Menon, and C. Aere A prospective study of cognitive impairment in ALS Neurology, November 1, 1999; 53(8): 1665 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P Rakowicz and J. R Hodges Dementia and aphasia in motor neuron disease: an underrecognised association? J. Neurol. Neurosurg. Psychiatry, December 1, 1998; 65(6): 881 - 889. [Abstract] [Full Text] |
||||
![]() |
A. Worthington Psychological aspects of motor neurone disease: a review Clinical Rehabilitation, August 1, 1996; 10(3): 185 - 194. [PDF] |
||||





